In animal models, apelin-transgenic mice were resistant to diet-induced obesity via stimulating energy expenditure [4] and administration of apelin-13 (a truncated apelin peptide with 13-amino acid) decreased body adiposity in diet-induced obese mice [5]. Here, APLN is linked to obesity disorder.